New research suggests that fluorodeoxyglucose (FDG) PET is better for assessing the severity of Alzheimer’s disease and mild cognitive impairment (MCI) than florbetapir-PET scans.

Chronic active lesions visible on brain MRI scans, identifiable by their “darkened outer rims,” are associated with multiple sclerosis, according to new findings published in JAMA Neurology.

There’s a strong case to be made for mammography to become a “dual test” for both breast cancer screening and cardiovascular disease (CVD) prevention, according to a new review published in the European Journal of Radiology.

With a sincere Thank You to everyone who took the time to complete RBJ’s first annual salary survey—more than 530 individuals—we’re delighted to present the results in the pages ahead.

Newly diagnosed HF patients with concomitant mitral regurgitation can expect more admissions, longer hospital stays and pricier medical bills than HF patients without MR, according to an analysis published in the American Journal of Cardiology.

Multiparametric MRI (mpMRI) scans and targeted biopsies can improve the detection of clinically significant prostate cancer, according to new research published in JAMA Network Open.

The U.S. Preventative Services Task Force (USPSTF) has released a statement recommending against screening for pancreatic cancer in asymptomatic adults.

A new study found that chronic kidney disease patients who received IV contrast-enhanced imaging faced no more risk of developing contrast-induced nephropathy than those who did not receive contrast material.